相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trypanosoma cruzi targets for new chemotherapeutic approaches
Maria Nazare C. Soeiro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Adaptive immune features of natural killer cells
Joseph C. Sun et al.
NATURE (2009)
Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library
Valeria Tekiel et al.
VACCINE (2009)
Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae)
Valeria P. Sulsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Use of proteoliposome as a vaccine against Trypanosoma cruzi in mice
Vanessa Migliaccio et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2008)
Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease
Eduardo L. V. Silveira et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice
Vandanajay Bhatia et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Benznidazole and Chagas disease: can an old drug be the answer to an old problem?
Charles Mady et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection
Lisa M. Bixby et al.
JOURNAL OF IMMUNOLOGY (2008)
Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease
Juan M. Bustamante et al.
NATURE MEDICINE (2008)
Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein
Bin Chou et al.
MICROBES AND INFECTION (2008)
Trypanosoma cruzi infection from the view of CD8+ T cell immunity -: An infection model for developing T cell vaccine
Yasushi Miyahira
PARASITOLOGY INTERNATIONAL (2008)
Trypanosoma cruzi infection by oral route How the interplay between parasite and host components modulates infectivity
Nobuko Yoshida
PARASITOLOGY INTERNATIONAL (2008)
Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Tryponosoma cruzi infection model
Silvia I. Cazorla et al.
VACCINE (2008)
Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Tryponosoma cruzi infection:: A vaccine candidate
German H. Fontanella et al.
VACCINE (2008)
Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi
M. Paola Zago et al.
INFECTION AND IMMUNITY (2008)
Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against trypanosoma cruzi
Silvia I. Cazorla et al.
INFECTION AND IMMUNITY (2008)
The challenges of chagas disease -: Grim outlook or glimmer of hope?
Rick L. Tarleton et al.
PLOS MEDICINE (2007)
Human defensin α-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction
A. Nia Madison et al.
INFECTION AND IMMUNITY (2007)
Alternative trans-splicing of the Trypanosoma cruzi LYT1 gene transcript results in compartmental and functional switch for the encoded protein
Karim Benabdellah et al.
MOLECULAR MICROBIOLOGY (2007)
Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression
Natalia Guinazu et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection:: Importance of a TLR9 agonist and CD4+ T cells
Bruna C. G. de Alencar et al.
VACCINE (2007)
Immune system recognition of Trypanosoma cruzi
Rick L. Tarleton
CURRENT OPINION IN IMMUNOLOGY (2007)
Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice
Gilma Sanchez-Burgos et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Parasite-induced chronic inflammation is not exacerbated by immunotherapy before or during Trypanosoma cruzi infection
Malcolm S. Duthie et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi
Carla Claser et al.
MICROBES AND INFECTION (2007)
Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi
Beatriz Basso et al.
VACCINE (2007)
Improved outcome of Trypanosoma cruzi infection in rats following treatment in early life with suspensions of heat-killed environmental Actinomycetales
G. H. Fontanella et al.
VACCINE (2007)
Endogenous CD4+ CD25+ regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice
Joshua Kotner et al.
INFECTION AND IMMUNITY (2007)
DNA vaccines against protozoan parasites: Advances and challenges
Eric Dumonteil
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2007)
The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection
Maria Morell et al.
VACCINE (2006)
During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single α-galactosylceramide treatment
Malcolm S. Duthie et al.
IMMUNOLOGY (2006)
A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats
Ester Roffe et al.
MICROBES AND INFECTION (2006)
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression
Johnson Rajasingh et al.
FASEB JOURNAL (2006)
Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease:: a possible role for suppressors of cytokine signaling 1 and 3
Vida A. Dennis et al.
INFECTION AND IMMUNITY (2006)
Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase
Alexandre V. Machado et al.
HUMAN GENE THERAPY (2006)
CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes
Diana L. Martin et al.
PLOS PATHOGENS (2006)
Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc13 Tul antigen of Trypanosoma cruzi
GA García et al.
PARASITOLOGY (2006)
Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice
F Tzelepis et al.
INFECTION AND IMMUNITY (2006)
Contribution of NKNK T, γδ T, and αβ T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi
LR Sardinha et al.
INFECTION AND IMMUNITY (2006)
Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice
H Zapata-Estrella et al.
IMMUNOLOGY LETTERS (2006)
Current status and future prospects for a vaccine against American trypanosomiasis
Vandanajay Bhatia et al.
EXPERT REVIEW OF VACCINES (2005)
Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection
Y Miyahira et al.
INFECTION AND IMMUNITY (2005)
Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection
M Chamekh et al.
INFECTION AND IMMUNITY (2005)
CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2
AFS Araújo et al.
INFECTION AND IMMUNITY (2005)
Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen
DF Hoft et al.
INFECTION AND IMMUNITY (2005)
The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease
NM El-Sayed et al.
SCIENCE (2005)
Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection
VRA Pereira et al.
PARASITOLOGY RESEARCH (2005)
NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection
MS Duthie et al.
INTERNATIONAL IMMUNOLOGY (2005)
CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi
FS Machado et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A 9,000-year record of Chagas' disease
AC Aufderheide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Jump-starting the immune system: prime-boosting comes of age
DL Woodland
TRENDS IN IMMUNOLOGY (2004)
Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis
APMP Marino et al.
CIRCULATION (2004)
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
DH Barouch et al.
IMMUNOLOGICAL REVIEWS (2004)
NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms
T Lieke et al.
INFECTION AND IMMUNITY (2004)
Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening
V Bhatia et al.
INFECTION AND IMMUNITY (2004)
Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice
E Dumonteil et al.
INFECTION AND IMMUNITY (2004)
Progress in DNA-based heterologous prime-boost immunization strategies for malaria
AC Moore et al.
IMMUNOLOGICAL REVIEWS (2004)
The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response
G Armengol et al.
MOLECULAR BIOTECHNOLOGY (2004)
Acute Trypanosoma cruzi infection:: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice
B Basso et al.
VACCINE (2004)
Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes
FM Frank et al.
VACCINE (2003)
Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection
BH Fralish et al.
VACCINE (2003)
In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice
BM Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection
SB Boscardin et al.
INFECTION AND IMMUNITY (2003)
分享论文
